Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: F.Hoffmann-La Roche
Woman and Man Max 99 years
F.Hoffmann-La Roche
Update Il y a 4 ans
A phase II Biomarker Identification Trial for Erlotinib (Tarceva®) in Patients with Advanced Pancreatic Carcinoma
Identification of biomarker(s) which may predict improvement in progression free survival from treatment with erlotinib
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
F.Hoffmann-La Roche
Update Il y a 4 ans
A Phase II study of Tarceva® in Combination with Avastin® versus chemotherapy plus Avastin® in 1st line advanced NSCLC patients
Estimate the hazard ratio for progression free survival (PFS) duration in patients with previously untreated advanced stage NSCLC for the combination of erlotinib plus bevacizumab relative to the comb...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
1
2